logo
logo
Sign in
ella turner
Followers 2 Following 0
ella turner 2022-09-16
img
In order to mitigate the aforementioned challenges, pharma and biotech companies are gradually adopting viral vaccine cell culture media for vaccines manufacturing. Further, in 1950s, an alternative technology based on animal cell culture, which used primary cells as substrate, was developed. One of the key objectives of this report was to evaluate the current opportunity and the future potential associated with the viral vaccine cell culture media market, over the coming decade. These cells can be cultured in flasks, roller bottles and other cell culture vessels capable of handling anchorage-dependent cell types. However, suspension cell culture lacks the benefit of direct visualization.
collect
0
ella turner 2022-07-29
img
Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Market, 2020-2030. html The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:§ A detailed assessment of the current market landscape of drug repurposing companies § Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
collect
0
ella turner 2022-06-22
img
html Cell lines have revolutionized scientific R&D and are currently being used for a myriad of applications. It requires cost intensive materials, specialized genetic engineering technologies, aseptic cell culturing conditions, specialized infrastructure for cell storage, and product-specific analytical techniques for cell / cell line testing. Therefore, outsourcing cell line development and characterization operations allows product developers to focus their efforts on R&D activities. What are the common sources, gene delivery methods, protein yield and affiliated services offered by the cell line development service providers? What are the anticipated future trends related to cell line development and characterization market?
collect
0
ella turner 2022-05-30
img
Roots Analysis has announced the addition of “Handheld Imaging Devices Market, 2020-2030” report to its list of offerings. html Key Market Insights Nearly 100 handheld ultrasound imaging devices are presently available / under developmentClose to 85% of the aforementioned scanners use linear and curved / convex transducer arrays. In addition, key value drivers in majority of the agreements were expansion of market reach and incorporation of advanced features in devices. 1%, between 2020 and 2030Presently, over 80,000 units of handheld ultrasound scanners are estimated to be used for diagnostic imaging purpose by physicians. html Key Questions Answered§ Who are the leading developers of handheld ultrasound imaging devices?
collect
0
ella turner 2022-08-18
img
Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings. html Key Market Insights  Over 175 drugs targeting the endocannabinoid system are currently under development Most cannabinoid-based drug candidates are being developed to target the CB1 and CB2 receptors. Nearly 45% of such drugs are presently being investigated in clinical trials, while 50% are in the preclinical / discovery phase. Further, grants (394) worth USD 147 million were awarded to research projects related to endocannabinoid system. html Key Questions Answered§ Who are the leading industry players in this market?
collect
0
ella turner 2022-07-27
img
html Key Market Insights Nearly 230 digital therapeutic solutions are currently available / under developmentClose to 45% of the aforementioned solutions are standalone software applications targeting more than 60 unique indications. Alternatively, some digital health products are designed to augment the effect of conventional therapeutics and are currently being considered for treating substance use disorders and few mental health problems. Close to 50% of such trials have been / are being conducted in the US. html One of the key objectives of the report was to estimate the existing digital health market size and the future opportunity for digital therapeutics developers over the next decade. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.
collect
0
ella turner 2022-06-20
img
To order this 795+ page report, which features 165+ figures and 270+ tables, please visit https://www. Examples of late-stage clinical candidates include bb2121, CD123/CLL1 CAR-T CD19 CAR-T and LCAR-B38M CAR-T / JNJ-68284528. html    Key Questions Answered§ Who are the leading industry and non-industry players in this market? The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.
collect
0
ella turner 2022-05-26
img
Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings. It includes insights based on the current status of biosimilar candidates, and important developer related details (including headquarters, and type of developer). In fact, a year after multiple adalimumab biosimilars were launched in Europe, the originator released a statement that its diverse product placement strategy was able to maintain profitability, despite the availability of enemy products. html Key Questions Answered§ Who are the key players engaged in the development of biosimilars of adalimumab? The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
collect
0
ella turner 2022-08-09
img
The future opportunity within the gene editing market has been segmented across [A] type of payment (upfront payment and milestone payment) and [B] geography (North America, Europe, and Asia Pacific and rest of the world). htmlTo request a sample copy / brochure of this report, please visit https://www. htmlKey Questions Answered§ Who are the players engaged in the development of gene editing therapies beyond CRISPR? The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.
collect
0
ella turner 2022-07-07
img
It is worth noting that, till date, many types (50+) of soft tissue sarcoma have been identified. htmlFor additional details, please visit https://www. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis. johnson@rootsanalysis.
collect
0
ella turner 2022-06-15
img
Roots Analysis has announced the addition of the (Avastin) Bevacizumab Biosimilars – Pipeline Review and Partnerships” report to its list of offerings. Considering that several enemy products are already in the market, and several others are under development, the bevacizumab biosimilar market is anticipated to witness noteworthy growth in the foreseen future. html Key Questions Answered§ Who are the key players engaged in the development of biosimilars of bevacizumab? The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.
collect
0
ella turner 2022-05-23
img
Roots Analysis has announced the addition of “Home Blood Collection Devices market, 2021-2030” report to its list of offerings. These devices are now being adopted by various CROs and diagnostic labs located across the globe owing to their various advantages. html  Key Market Insights  Close to 40% companies were established, during the period 2010 - 2014The current market landscape is dominated by small players, which constitute 58% of the total number of stakeholders. Further, more than 30 firms claim to have marketed devices in their respective portfolios. Further, majority of devices (85%) employ the fingerstick method for collection of samples, in the range of 50-100 microliters.
collect
0
ella turner 2022-08-04
img
Roots Analysis has announced the addition of “Fc Fusion Therapeutics Market, 2021-2030” report to its list of offerings. The success of these biopharmaceutical products can be attributed to their diverse biological and pharmacological properties, including an extended serum half-lifeTo order this 130+ page report, which features 95+ figures and 140+ tables, please visit https://www. This is followed by more than 30% of the Fc fusion therapeutics which are already marketed for various disease indications. html  Key Questions Answered§ Who are the leading players involved in the development of Fc fusion therapeutics? comFacebook - https://www.
collect
0
ella turner 2022-06-29
img
Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs  Market, 2019-2030. html    Amongst other elements, the report includes:§ A detailed review of the current Medical Device CRO market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain. Key companies covered in the report§ CTI Clinical Trial and Consulting Services§ CROMSOURCE§ ICON§ Intertek§ Medpace§ MIC Medical§ North American Science Associates (NAMSA)§ Parexel§ PharmaLex§ Premier Research § Société Générale de Surveillance (SGS)§ Underwriters Laboratory (UL) For more information please click on the following linkhttps://www. html   Other Recent Offerings1. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
collect
0
ella turner 2022-06-09
img
Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings. html Key Market Insights  Presently, more than 80 players claim to offer services for antibody discovery Over 90% of the aforementioned players provide services for hit generation, followed by those offering services for antibody humanization (58%). It is worth mentioning that five service providers claim to have the required expertise to serve as one-stop-shops for all the antibody discovery steps. It is worth mentioning that the market for antibody discovery platforms in Asia-pacific is anticipated to grow at a relatively faster pace, during the forecast period. html  Key Questions Answered§ Who are the leading players engaged in offering services and platforms for antibody discovery?
collect
0
ella turner 2022-05-02
img
html      The development and characterization of cell lines is both technically challenging and financially demanding. It requires cost intensive materials, specialized genetic engineering technologies, aseptic cell culturing conditions, specialized infrastructure for cell storage, and product-specific analytical techniques for cell / cell line testing. Therefore, outsourcing cell line development and characterization operations allows product developers to focus their efforts on R&D activities. What kind of CDMO support is available for cell line development, across different regions? What are the common sources, gene delivery methods, protein yield and affiliated services offered by the cell line development service providers?
collect
0
ella turner 2022-09-16
img
In order to mitigate the aforementioned challenges, pharma and biotech companies are gradually adopting viral vaccine cell culture media for vaccines manufacturing. Further, in 1950s, an alternative technology based on animal cell culture, which used primary cells as substrate, was developed. One of the key objectives of this report was to evaluate the current opportunity and the future potential associated with the viral vaccine cell culture media market, over the coming decade. These cells can be cultured in flasks, roller bottles and other cell culture vessels capable of handling anchorage-dependent cell types. However, suspension cell culture lacks the benefit of direct visualization.
ella turner 2022-08-09
img
The future opportunity within the gene editing market has been segmented across [A] type of payment (upfront payment and milestone payment) and [B] geography (North America, Europe, and Asia Pacific and rest of the world). htmlTo request a sample copy / brochure of this report, please visit https://www. htmlKey Questions Answered§ Who are the players engaged in the development of gene editing therapies beyond CRISPR? The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.
ella turner 2022-07-29
img
Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Market, 2020-2030. html The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:§ A detailed assessment of the current market landscape of drug repurposing companies § Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
ella turner 2022-07-07
img
It is worth noting that, till date, many types (50+) of soft tissue sarcoma have been identified. htmlFor additional details, please visit https://www. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis. johnson@rootsanalysis.
ella turner 2022-06-22
img
html Cell lines have revolutionized scientific R&D and are currently being used for a myriad of applications. It requires cost intensive materials, specialized genetic engineering technologies, aseptic cell culturing conditions, specialized infrastructure for cell storage, and product-specific analytical techniques for cell / cell line testing. Therefore, outsourcing cell line development and characterization operations allows product developers to focus their efforts on R&D activities. What are the common sources, gene delivery methods, protein yield and affiliated services offered by the cell line development service providers? What are the anticipated future trends related to cell line development and characterization market?
ella turner 2022-06-15
img
Roots Analysis has announced the addition of the (Avastin) Bevacizumab Biosimilars – Pipeline Review and Partnerships” report to its list of offerings. Considering that several enemy products are already in the market, and several others are under development, the bevacizumab biosimilar market is anticipated to witness noteworthy growth in the foreseen future. html Key Questions Answered§ Who are the key players engaged in the development of biosimilars of bevacizumab? The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.
ella turner 2022-05-30
img
Roots Analysis has announced the addition of “Handheld Imaging Devices Market, 2020-2030” report to its list of offerings. html Key Market Insights Nearly 100 handheld ultrasound imaging devices are presently available / under developmentClose to 85% of the aforementioned scanners use linear and curved / convex transducer arrays. In addition, key value drivers in majority of the agreements were expansion of market reach and incorporation of advanced features in devices. 1%, between 2020 and 2030Presently, over 80,000 units of handheld ultrasound scanners are estimated to be used for diagnostic imaging purpose by physicians. html Key Questions Answered§ Who are the leading developers of handheld ultrasound imaging devices?
ella turner 2022-05-23
img
Roots Analysis has announced the addition of “Home Blood Collection Devices market, 2021-2030” report to its list of offerings. These devices are now being adopted by various CROs and diagnostic labs located across the globe owing to their various advantages. html  Key Market Insights  Close to 40% companies were established, during the period 2010 - 2014The current market landscape is dominated by small players, which constitute 58% of the total number of stakeholders. Further, more than 30 firms claim to have marketed devices in their respective portfolios. Further, majority of devices (85%) employ the fingerstick method for collection of samples, in the range of 50-100 microliters.
ella turner 2022-08-18
img
Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings. html Key Market Insights  Over 175 drugs targeting the endocannabinoid system are currently under development Most cannabinoid-based drug candidates are being developed to target the CB1 and CB2 receptors. Nearly 45% of such drugs are presently being investigated in clinical trials, while 50% are in the preclinical / discovery phase. Further, grants (394) worth USD 147 million were awarded to research projects related to endocannabinoid system. html Key Questions Answered§ Who are the leading industry players in this market?
ella turner 2022-08-04
img
Roots Analysis has announced the addition of “Fc Fusion Therapeutics Market, 2021-2030” report to its list of offerings. The success of these biopharmaceutical products can be attributed to their diverse biological and pharmacological properties, including an extended serum half-lifeTo order this 130+ page report, which features 95+ figures and 140+ tables, please visit https://www. This is followed by more than 30% of the Fc fusion therapeutics which are already marketed for various disease indications. html  Key Questions Answered§ Who are the leading players involved in the development of Fc fusion therapeutics? comFacebook - https://www.
ella turner 2022-07-27
img
html Key Market Insights Nearly 230 digital therapeutic solutions are currently available / under developmentClose to 45% of the aforementioned solutions are standalone software applications targeting more than 60 unique indications. Alternatively, some digital health products are designed to augment the effect of conventional therapeutics and are currently being considered for treating substance use disorders and few mental health problems. Close to 50% of such trials have been / are being conducted in the US. html One of the key objectives of the report was to estimate the existing digital health market size and the future opportunity for digital therapeutics developers over the next decade. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.
ella turner 2022-06-29
img
Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs  Market, 2019-2030. html    Amongst other elements, the report includes:§ A detailed review of the current Medical Device CRO market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain. Key companies covered in the report§ CTI Clinical Trial and Consulting Services§ CROMSOURCE§ ICON§ Intertek§ Medpace§ MIC Medical§ North American Science Associates (NAMSA)§ Parexel§ PharmaLex§ Premier Research § Société Générale de Surveillance (SGS)§ Underwriters Laboratory (UL) For more information please click on the following linkhttps://www. html   Other Recent Offerings1. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
ella turner 2022-06-20
img
To order this 795+ page report, which features 165+ figures and 270+ tables, please visit https://www. Examples of late-stage clinical candidates include bb2121, CD123/CLL1 CAR-T CD19 CAR-T and LCAR-B38M CAR-T / JNJ-68284528. html    Key Questions Answered§ Who are the leading industry and non-industry players in this market? The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.
ella turner 2022-06-09
img
Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings. html Key Market Insights  Presently, more than 80 players claim to offer services for antibody discovery Over 90% of the aforementioned players provide services for hit generation, followed by those offering services for antibody humanization (58%). It is worth mentioning that five service providers claim to have the required expertise to serve as one-stop-shops for all the antibody discovery steps. It is worth mentioning that the market for antibody discovery platforms in Asia-pacific is anticipated to grow at a relatively faster pace, during the forecast period. html  Key Questions Answered§ Who are the leading players engaged in offering services and platforms for antibody discovery?
ella turner 2022-05-26
img
Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings. It includes insights based on the current status of biosimilar candidates, and important developer related details (including headquarters, and type of developer). In fact, a year after multiple adalimumab biosimilars were launched in Europe, the originator released a statement that its diverse product placement strategy was able to maintain profitability, despite the availability of enemy products. html Key Questions Answered§ Who are the key players engaged in the development of biosimilars of adalimumab? The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
ella turner 2022-05-02
img
html      The development and characterization of cell lines is both technically challenging and financially demanding. It requires cost intensive materials, specialized genetic engineering technologies, aseptic cell culturing conditions, specialized infrastructure for cell storage, and product-specific analytical techniques for cell / cell line testing. Therefore, outsourcing cell line development and characterization operations allows product developers to focus their efforts on R&D activities. What kind of CDMO support is available for cell line development, across different regions? What are the common sources, gene delivery methods, protein yield and affiliated services offered by the cell line development service providers?